We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich
News

Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich

Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich
News

Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Application specialists from Tecan have teamed up with Technoclone GmbH, Vienna, and the University Children’s Hospital in Zurich to validate the TECHNOTHROMBIN® thrombin generation assay (TGA) for Tecan’s Infinite® M200 multimode microplate reader.

Dr Oliver Speer, head of the Experimental Hematology and Erythrocyte Laboratory at the hospital, explained: “We installed the Infinite reader in our laboratory to standardize all of our photometric assays using just a single platform. Once we had completed the transfer of our existing assays to the Infinite, we realized that the flexibility and sensitivity of the instrument would allow us to supersede some of these assays with more efficient or sensitive methods, so became interested in the TECHNOTHROMBIN TGA.”

“Representatives from Tecan and Technoclone came to the hospital to assist with development and validation of this assay on the Infinite reader, enabling us to very quickly complete our validation study. The collaboration between the two companies was perfect for us, and we are still in regular contact with Tecan for technical assistance. The support we have received has been excellent, and Tecan has even developed the software specifically for our needs.”
Advertisement